ITFI920052A1 - Proteina estratta da ceppi citotossici di helicobacter pylori, gene che la esprime, uso della proteina come vaccino o diagnostico. - Google Patents
Proteina estratta da ceppi citotossici di helicobacter pylori, gene che la esprime, uso della proteina come vaccino o diagnostico.Info
- Publication number
- ITFI920052A1 ITFI920052A1 IT000052A ITFI920052A ITFI920052A1 IT FI920052 A1 ITFI920052 A1 IT FI920052A1 IT 000052 A IT000052 A IT 000052A IT FI920052 A ITFI920052 A IT FI920052A IT FI920052 A1 ITFI920052 A1 IT FI920052A1
- Authority
- IT
- Italy
- Prior art keywords
- antigen
- helicobacter pylori
- protein
- vaccine
- expresses
- Prior art date
Links
- 241000590002 Helicobacter pylori Species 0.000 title abstract 5
- 229940037467 helicobacter pylori Drugs 0.000 title abstract 5
- 108090000623 proteins and genes Proteins 0.000 title abstract 4
- 102000004169 proteins and genes Human genes 0.000 title abstract 3
- 231100000433 cytotoxic Toxicity 0.000 title 1
- 230000001472 cytotoxic effect Effects 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
- 239000000427 antigen Substances 0.000 abstract 8
- 102000036639 antigens Human genes 0.000 abstract 8
- 108091007433 antigens Proteins 0.000 abstract 8
- 208000015181 infectious disease Diseases 0.000 abstract 3
- 101710112752 Cytotoxin Proteins 0.000 abstract 2
- 231100000599 cytotoxic agent Toxicity 0.000 abstract 2
- 239000002619 cytotoxin Substances 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 150000007523 nucleic acids Chemical class 0.000 abstract 2
- 238000003556 assay Methods 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 230000014726 immortalization of host cell Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Priority Applications (25)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITFI920052A IT1262895B (it) | 1992-03-02 | 1992-03-02 | Proteina estratta da ceppi citotossici di helicobacter pylori, gene che la esprime, uso della proteina come vaccino o diagnostico. |
AT93905285T ATE245698T1 (de) | 1992-03-02 | 1993-03-02 | Mit dem cytotoxin von helicobacter pylori assoziiertes, immunodominantes antigen verwendbar in impfstoffen und zur diagnose |
JP51530993A JP3368902B2 (ja) | 1992-03-02 | 1993-03-02 | ワクチンおよび診断に有用なHelicobacterpyloriタンパク質 |
AT99202698T ATE382692T1 (de) | 1992-03-02 | 1993-03-02 | Helicobacter pylori cytotoxin verwendbar in impfstoffe und diagnostik |
DE69333110T DE69333110T2 (de) | 1992-03-02 | 1993-03-02 | Mit dem cytotoxin von helicobacter pylori assoziiertes, immunodominantes antigen verwendbar in impfstoffen und zur diagnose |
EP93905285A EP0643770B1 (en) | 1992-03-02 | 1993-03-02 | Helicobacter pylori cytotoxin associated immunodominant antigen useful for vaccines and diagnostics |
CA002131729A CA2131729C (en) | 1992-03-02 | 1993-03-02 | Helicobacter pylori proteins useful for vaccines and diagnostics |
SG1996009100A SG48353A1 (en) | 1992-03-02 | 1993-03-02 | Helicobacter pylori proteins useful for vaccines and diagnostics |
CA002383007A CA2383007A1 (en) | 1992-03-02 | 1993-03-02 | Helicobacter pylori proteins useful for vaccines and diagnostics |
DE69334197T DE69334197T2 (de) | 1992-03-02 | 1993-03-02 | Helicobacter pylori Cytotoxin verwendbar in Impfstoffe und Diagnostik |
AU36300/93A AU3630093A (en) | 1992-03-02 | 1993-03-02 | Helicobacter pylori proteins useful for vaccines and diagnostics |
EP99202698A EP0967279B1 (en) | 1992-03-02 | 1993-03-02 | Helicobacter pylori cytotoxin useful for vaccines and diagnostics |
PCT/EP1993/000472 WO1993018150A1 (en) | 1992-03-02 | 1993-03-02 | Helicobacter pylori proteins useful for vaccines and diagnostics |
US08/471,491 US6090611A (en) | 1992-03-02 | 1995-06-06 | Helicobacter pylori proteins useful for vaccines and diagnostics |
US08/470,260 US6077706A (en) | 1992-03-02 | 1995-06-06 | Helicobacter pylori proteins useful for vaccines and diagnostics |
US08/466,662 US6130059A (en) | 1992-03-02 | 1995-06-06 | Helicobacter pylori proteins useful for vaccines and diagnostics |
US08/477,451 US5928865A (en) | 1992-03-02 | 1995-06-07 | Compositions comprising isolated Helicobacter pylori CagI polynucleotides and method of preparation thereof |
US09/360,685 US7141244B1 (en) | 1992-03-02 | 1999-07-26 | Helicobacter pylori proteins useful for vaccines and diagnostics |
JP2000126696A JP2000333686A (ja) | 1992-03-02 | 2000-04-26 | ワクチンおよび診断に有用なHelicobacterpyloriタンパク質 |
JP2000126695A JP3408494B2 (ja) | 1992-03-02 | 2000-04-26 | ワクチンおよび診断に有用なHelicobacterpyloriタンパク質 |
US09/921,157 US20040048353A1 (en) | 1992-03-02 | 2001-08-02 | Helicobacter pylori proteins useful for vaccines and diagnostics |
JP2003008806A JP4271952B2 (ja) | 1992-03-02 | 2003-01-16 | ワクチンおよび診断に有用なHelicobacterpyloriタンパク質 |
US10/615,668 US7700755B2 (en) | 1992-03-02 | 2003-07-08 | Helicobacter pylori CAI antigen |
JP2005263068A JP2006055168A (ja) | 1992-03-02 | 2005-09-09 | ワクチンおよび診断に有用なHelicobacterpyloriタンパク質 |
US11/580,632 US20070243204A1 (en) | 1992-03-02 | 2006-10-12 | Helicobacter pylori proteins useful for vaccines and diagnostics |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITFI920052A IT1262895B (it) | 1992-03-02 | 1992-03-02 | Proteina estratta da ceppi citotossici di helicobacter pylori, gene che la esprime, uso della proteina come vaccino o diagnostico. |
Publications (3)
Publication Number | Publication Date |
---|---|
ITFI920052A0 ITFI920052A0 (it) | 1992-03-02 |
ITFI920052A1 true ITFI920052A1 (it) | 1993-09-02 |
IT1262895B IT1262895B (it) | 1996-07-22 |
Family
ID=11349982
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITFI920052A IT1262895B (it) | 1992-03-02 | 1992-03-02 | Proteina estratta da ceppi citotossici di helicobacter pylori, gene che la esprime, uso della proteina come vaccino o diagnostico. |
Country Status (6)
Country | Link |
---|---|
US (1) | US6090611A (it) |
EP (1) | EP0643770B1 (it) |
JP (1) | JP4271952B2 (it) |
AT (2) | ATE245698T1 (it) |
IT (1) | IT1262895B (it) |
SG (1) | SG48353A1 (it) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7141244B1 (en) * | 1992-03-02 | 2006-11-28 | Chiron Srl | Helicobacter pylori proteins useful for vaccines and diagnostics |
AU3630093A (en) * | 1992-03-02 | 1993-10-05 | Biocine S.P.A. | Helicobacter pylori proteins useful for vaccines and diagnostics |
ATE229978T1 (de) * | 1994-07-01 | 2003-01-15 | Chiron Corp | Helicobacter proteine und impstoffe |
ES2283012T3 (es) * | 1996-01-04 | 2007-10-16 | Novartis Vaccines And Diagnostics, Inc. | Bacterioferritina de helicobacter pylori. |
US20060269532A1 (en) * | 1997-02-25 | 2006-11-30 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
US20030185830A1 (en) * | 1997-02-25 | 2003-10-02 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
US20060024301A1 (en) * | 1997-02-25 | 2006-02-02 | Corixa Corporation | Prostate-specific polypeptides and fusion polypeptides thereof |
US7517952B1 (en) * | 1997-02-25 | 2009-04-14 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
WO1999057278A2 (en) | 1998-04-30 | 1999-11-11 | Chiron S.P.A. | IMMUNIZATION AGAINST AND TREATMENT FOR INFECTION BY $i(H.PYLORI) |
US6764687B1 (en) * | 1999-06-09 | 2004-07-20 | Akzo Nobel N.V. | Live attenuated bacteria for use in a vaccine |
US7179609B1 (en) | 2000-10-04 | 2007-02-20 | Atrophus Ab | Screening method for gastritis |
US7048931B1 (en) | 2000-11-09 | 2006-05-23 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
US20020107368A1 (en) * | 2000-12-07 | 2002-08-08 | Jing-Hui Tian | Helicobacter proteins, gene sequences and uses thereof |
EP1423142A1 (en) * | 2001-08-31 | 2004-06-02 | Chiron SRL. | Helicobacter pylori vaccination with a combination of caga, vaca and nap proteins |
SE0200974D0 (sv) | 2002-03-27 | 2002-03-27 | Phagen Ab | Screening method for gastritis |
US20060078919A1 (en) * | 2004-09-08 | 2006-04-13 | Harry C. Gurney Janice Gurney | Diagnostic test kit and methods of diagnosis and treatment of helicobacter SPP. associated infections |
WO2006055623A2 (en) * | 2004-11-17 | 2006-05-26 | Drexel University | Method and compositions for prevention and treatment of malaria infections |
EP1853914B1 (en) * | 2005-01-25 | 2015-04-22 | The Johns Hopkins University | Plasmodium diagnostic assay |
ES2532942T3 (es) | 2006-03-01 | 2015-04-06 | Aduro Biotech | Listeria obtenida por ingeniería genética y métodos de uso de la misma |
CN103415620B (zh) | 2010-11-17 | 2016-10-12 | 艾杜罗生物科技公司 | 诱导针对EGFRvIII的免疫应答的方法和组合物 |
EA034702B1 (ru) | 2011-04-26 | 2020-03-10 | Молекулар Экспресс, Инк. | Липосомные композиции |
IN2014MN02492A (it) | 2012-06-08 | 2015-07-17 | Aduro Biotech | |
SG11201502770PA (en) | 2012-11-06 | 2015-06-29 | Aduro Biotech Inc | Facultatively attenuated bacterial species and methods of preparation and use thereof |
AU2013358892B2 (en) | 2012-12-13 | 2018-06-21 | Aduro Biotech, Inc. | Compositions comprising cyclic purine dinucleotides having defined stereochemistries and methods for their preparation and use |
BR112015015076A2 (pt) | 2012-12-27 | 2018-10-30 | Aduro Biotech Inc | parceiros de fusão de peptídeo sinal que facilitam a expressão listerial de sequências antigênicas e métodos de preparação e uso dos mesmos. |
SG10201708821RA (en) | 2013-04-29 | 2017-12-28 | Memorial Sloan Kettering Cancer Center | Compositions and methods for altering second messenger signaling |
WO2014179760A1 (en) | 2013-05-03 | 2014-11-06 | The Regents Of The University Of California | Cyclic di-nucleotide induction of type i interferon |
AP2015008700A0 (en) | 2013-05-18 | 2015-08-31 | Univ California | Compositions and methods for activating "stimulator of interferon gene"-dependent signalling |
US9549944B2 (en) | 2013-05-18 | 2017-01-24 | Aduro Biotech, Inc. | Compositions and methods for inhibiting “stimulator of interferon gene”—dependent signalling |
EP3027227A4 (en) | 2013-07-31 | 2018-05-23 | Memorial Sloan Kettering Cancer Center | Sting crystals and modulators |
US10925945B2 (en) | 2014-10-13 | 2021-02-23 | Providence Health & Services-Oregon | Bacterial vaccines deficient in the 2-C-methyl-D-erythritol-4-phosphate pathway and methods of preparation and use thereof |
WO2016073381A1 (en) | 2014-11-03 | 2016-05-12 | Cerus Corporation | Compositions and methods for improved car-t cell therapies |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5459041A (en) * | 1988-02-18 | 1995-10-17 | Enteric Research Laboratories, Inc. | Campylobacter pylori antigens and uses thereof for detection of Campylobacter pylori infection |
US4882271A (en) * | 1988-03-10 | 1989-11-21 | Baylor College Of Medicine | Process for preparation of high molecular weight cell-associated protein of campylobacter pylori and use for serological detection of campylobacter pylori infection |
FR2637612B1 (fr) * | 1988-10-06 | 1993-09-10 | Pasteur Institut | Sequences de nucleotides codant pour une proteine a activite ureasique |
GB8928625D0 (en) * | 1989-12-19 | 1990-02-21 | 3I Res Expl Ltd | H.pylori dna probes |
US5292658A (en) * | 1989-12-29 | 1994-03-08 | University Of Georgia Research Foundation, Inc. Boyd Graduate Studies Research Center | Cloning and expressions of Renilla luciferase |
US5354854A (en) * | 1991-11-07 | 1994-10-11 | The Curators Of The University Of Missouri | Expression system for use in plants to suppress foreign expression and method |
US5403924A (en) * | 1992-10-13 | 1995-04-04 | Vanderbilt University | Taga gene and methods for detecting predisposition to peptic ulceration |
-
1992
- 1992-03-02 IT ITFI920052A patent/IT1262895B/it active IP Right Grant
-
1993
- 1993-03-02 AT AT93905285T patent/ATE245698T1/de active
- 1993-03-02 SG SG1996009100A patent/SG48353A1/en unknown
- 1993-03-02 EP EP93905285A patent/EP0643770B1/en not_active Expired - Lifetime
- 1993-03-02 AT AT99202698T patent/ATE382692T1/de active
-
1995
- 1995-06-06 US US08/471,491 patent/US6090611A/en not_active Expired - Lifetime
-
2003
- 2003-01-16 JP JP2003008806A patent/JP4271952B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
IT1262895B (it) | 1996-07-22 |
US6090611A (en) | 2000-07-18 |
SG48353A1 (en) | 1998-04-17 |
ITFI920052A0 (it) | 1992-03-02 |
EP0643770A1 (en) | 1995-03-22 |
ATE245698T1 (de) | 2003-08-15 |
EP0643770B1 (en) | 2003-07-23 |
ATE382692T1 (de) | 2008-01-15 |
JP4271952B2 (ja) | 2009-06-03 |
JP2003199567A (ja) | 2003-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ITFI920052A1 (it) | Proteina estratta da ceppi citotossici di helicobacter pylori, gene che la esprime, uso della proteina come vaccino o diagnostico. | |
CA2131729A1 (en) | Helicobacter pylori proteins useful for vaccines and diagnostics | |
EP2168596A3 (en) | Immunisation against chlamydia trachomatis | |
DE69734882D1 (de) | Dna immunisierung gegen chlamydia infektion | |
AU2001276619A1 (en) | Immunisation against chlamydia pneumoniae | |
MY119003A (en) | Bacterial antigens and vaccine compositions | |
ATE375391T1 (de) | Chlamydia-antigene und entsprechende dna- fragmente und deren verwendungen | |
RU95105518A (ru) | Применение мутантов вируса герпеса, вакцина | |
Minnick et al. | Cell entry and the pathogenesis of Bartonella infections | |
ATE355375T1 (de) | Bakterioferritin aus helicobacter pylori | |
CA2217522A1 (en) | Isolated frpb nucleic acid molecule and vaccine | |
DE69515340D1 (de) | Impfstoff gegen mycobakterielle infektionen | |
NZ526879A (en) | Genes and proteins, and their use | |
EP2172214A3 (en) | Chlamydia antigens and corresponding DNA fragments and uses thereof | |
ATE366583T1 (de) | Identifizierung von spezifischen differenziell exprimierten antigenen aus mycobacterium und medizinische verwendung der mycobakteriumproteine rv0068 und rv3407 | |
WO1995020658A3 (en) | Diagnosis and treatment of infections due to streptococci and enterococci | |
WO1992003553A1 (en) | Footrot vaccine | |
CN102209555B (zh) | 含有分选酶锚定乳房链球菌表面蛋白的组合物 | |
Iwanaga et al. | Pili of Vibrio cholerae widely distributed in serogroup O1 strains | |
EA200100701A1 (ru) | Белки наружной поверхности, их гены и их применение | |
US20060051363A1 (en) | Protein inducing cell death of helicobacter pylori | |
WO2000011183A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
DE69925927D1 (de) | Mutmassliches 98 kd protein des aussenmembrans von chlamydia und dafür kodierende dns sowie deren verwendung | |
NZ512448A (en) | Chlamydia antigens and corresponding DNA fragments and uses thereof | |
Hodges et al. | Immunodominant region of EDP 208 pili: Antigen-antibody interaction. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
0001 | Granted | ||
TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19980327 |